Accelerating development to meet clinical need has never been more urgent in the pandemic era. Exploristics can help fast-track clinical development with our uniquely targeted approach, increasing clinical study success while reducing risks and costs. Many of our development solutions are built around our transformative trial design software, KerusCloud. This cloud-based SaaS simulation platform allows clinical development teams to explore multiple study design and analysis options in silico, in minutes, for earlier data-driven design decisions. With KerusCloud, clinical studies can be extensively optimised statistically from the outset, maximising their chances of success.
Now, we are delighted to announce the launch of the latest Spring 2021 release of our ground-breaking KerusCloud software. This exciting new release includes a range of innovative features tailored to provide further quantitative insights to support evidence-based decision-making during clinical protocol development. To find out more about its range of new features and benefits, please join us for a free live introductory webinar during May to July 2021, hosted by Exploristics’ CEO, Aiden Flynn.
So, get ahead of the curve and reserve your free seat now for a software demonstration and live interactive discussion with Q&As. Discover more about the power of cloud-based study simulation. Discover KerusCloud.
Copyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.